← back to search

Edward J. Wild

Huntington's Disease Association ·
Area of research
Cellular and Molecular Neuroscience · Neurology
Research interest
Research interests include Genetic Neurodegenerative Diseases, Mitochondrial Function and Pathology, Neurological disorders and treatments, and Amyotrophic Lateral Sclerosis Research.
h-index
54
citations
12,500
works
201
NIH funding
primary concept
email

Recent publications

Huntington’s disease mice and human brain tissue exhibit increased G3BP1 granules and TDP43 mislocalization
Journal of Clinical Investigation 2021cited by 66position: middledoi
Kynurenine pathway metabolites in cerebrospinal fluid and blood as potential biomarkers in Huntington's disease
Journal of Neurochemistry 2021cited by 35position: lastdoi
Brain-derived neurotrophic factor in cerebrospinal fluid and plasma is not a biomarker for Huntington’s disease
Scientific Reports 2021cited by 30position: lastdoi
Huntington disease: new insights into molecular pathogenesis and therapeutic opportunities
Nature Reviews Neurology 2020cited by 515position: lastdoi
Biological and clinical characteristics of gene carriers far from predicted onset in the Huntington's disease Young Adult Study (HD-YAS): a cross-sectional analysis
The Lancet Neurology 2020cited by 184position: middledoi
Mutant huntingtin and neurofilament light have distinct longitudinal dynamics in Huntington’s disease
Science Translational Medicine 2020cited by 105position: lastdoi
Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology
JAMA Neurology 2019cited by 750position: lastdoi
MSH3 modifies somatic instability and disease severity in Huntington’s and myotonic dystrophy type 1
Brain 2019cited by 164position: middledoi
Characterizing White Matter in Huntington's Disease
Movement Disorders Clinical Practice 2019cited by 32position: lastdoi
Evaluation of mutant huntingtin and neurofilament proteins as potential markers in Huntington’s disease
Science Translational Medicine 2018cited by 198position: lastdoi
Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: a retrospective cohort analysis
The Lancet Neurology 2017cited by 355position: lastdoi
Quantification of huntingtin protein species in Huntington’s disease patient leukocytes using optimised electrochemiluminescence immunoassays
PLoS ONE 2017cited by 20position: middledoi
Huntington disease
Nature Reviews Disease Primers 2015cited by 1,551position: middledoi
Huntington disease: natural history, biomarkers and prospects for therapeutics
Nature Reviews Neurology 2014cited by 1,005position: middledoi
Mutant huntingtin fragmentation in immune cells tracks Huntington’s disease progression
Journal of Clinical Investigation 2012cited by 149position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Rachael I. Scahill · Huntington's Disease Association10 papers (2012–2021)Sarah J. Tabrizi · Huntington's Disease Association8 papers (2012–2020)Lauren M. Byrne · Queen Mary University of London7 papers (2017–2021)Filipe B. Rodrigues · University of Arkansas for Medical Sciences6 papers (2017–2021)Enrico De Vita · King's College London5 papers (2018–2021)Eileanoir B. Johnson · University of Iowa5 papers (2018–2021)Blair R. Leavitt · University of British Columbia Hospital3 papers (2014–2017) · 3 papers (2020–2021)Christopher A. Ross · Analog Devices (United States)3 papers (2014–2020)Amanda Heslegrave · UK Dementia Research Institute3 papers (2018–2021)Henrik Zetterberg · Indian Institute of Science Bangalore3 papers (2018–2021) · 2 papers (2012–2017)Gillian P. Bates · Queen Mary University of London2 papers (2012–2015)P. A. Wijeratne · University of Iowa2 papers (2018–2020)Daniel C. Alexander · Hawassa University2 papers (2018–2020)Ruth Farmer · London School of Hygiene & Tropical Medicine2 papers (2012–2017) · 2 papers (2012–2017) · 2 papers (2020–2021)Scott Schobel · University of Iowa2 papers (2018–2020)Douglas R. Langbehn · London School of Hygiene & Tropical Medicine2 papers (2014–2017)